University of Pittsburgh - Hillman Cancer Center — Pittsburgh, Pennsylvania

University of Pittsburgh - Hillman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232-1301.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Pittsburgh - Hillman Cancer Center has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Castrate-Resistant Prostate Cancer, B-cell Non-Hodgkin Lymphoma, Multiple Myeloma.

Sponsors: Hoffmann-La Roche, Bristol-Myers Squibb, Miltenyi Biomedicine GmbH.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pittsburgh - Hillman Cancer Center?

University of Pittsburgh - Hillman Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pittsburgh - Hillman Cancer Center conducted?

University of Pittsburgh - Hillman Cancer Center has 5 clinical trials on record, with 3 currently active. Their work covers Castrate-Resistant Prostate Cancer, B-cell Non-Hodgkin Lymphoma, Multiple Myeloma.

Is University of Pittsburgh - Hillman Cancer Center accredited by Crixeo Health?

University of Pittsburgh - Hillman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pittsburgh - Hillman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.